NCT02108210View on ClinicalTrials.gov

Cytokine Inhibition in Chronic Fatigue Syndrome Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

May 31, 2016

Conditions
Chronic Fatigue Syndrome
Interventions
DRUG

Anakinra

DRUG

Placebo

Trial Locations (1)

6500HB

RadboudUMC, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT02108210 - Cytokine Inhibition in Chronic Fatigue Syndrome Patients | Biotech Hunter | Biotech Hunter